|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
41,560,000 |
Market
Cap: |
317.52(M) |
Last
Volume: |
5,200 |
Avg
Vol: |
5,186 |
52
Week Range: |
$3.61 - $10.69 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Axogen is focused on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Co.'s platform for peripheral nerve repair features a portfolio of products, including Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; and Axoguard Nerve Connector, a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Co. also provides Axotouch Two-Point Discriminator, which is used to measure the innervation density of any surface area of the skin.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
30,000 |
30,000 |
Total Buy Value |
$0 |
$0 |
$188,940 |
$188,940 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
3 |
Total Shares Sold |
56,772 |
118,082 |
130,582 |
368,410 |
Total Sell Value |
$436,008 |
$980,899 |
$1,074,708 |
$3,484,755 |
Total People Sold |
4 |
5 |
6 |
6 |
Total Sell Transactions |
4 |
6 |
7 |
21 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Schiaparelli Jill F |
SVP, Bus. Strategy&Marketing |
|
2012-11-14 |
4 |
B |
$2.66 |
$1,995 |
D/D |
750 |
750 |
2.66 |
- |
|
Harper John Frederick |
Director |
|
2012-10-01 |
4 |
B |
$3.61 |
$312,471 |
D/D |
86,557 |
147,428 |
2.39 |
- |
|
Gold Mark Stephen |
Director |
|
2012-05-10 |
4 |
OE |
$0.27 |
$2,358 |
D/D |
8,733 |
14,188 |
|
- |
|
Friedman Mark Louis |
Vice President of RA/QA |
|
2011-12-23 |
4 |
OE |
$0.27 |
$1,530 |
D/D |
5,665 |
5,665 |
|
- |
|
Zaderej Karen L. |
Chief Executive Officer |
|
2011-12-19 |
4 |
OE |
$0.27 |
$20,720 |
D/D |
76,741 |
119,790 |
|
- |
|
Freitag Gregory Gene |
CFO |
|
2011-11-22 |
4 |
B |
$2.87 |
$26,250 |
D/D |
9,000 |
15,000 |
2.81 |
- |
|
Freitag Gregory Gene |
CFO |
|
2011-11-21 |
4 |
B |
$2.86 |
$17,395 |
D/D |
6,000 |
6,000 |
2.81 |
- |
|
Rudelius Robert James |
Director |
|
2011-11-05 |
4 |
B |
$2.70 |
$9,450 |
D/D |
3,500 |
13,955 |
2.39 |
- |
|
Rudelius Robert James |
Director |
|
2011-11-02 |
4 |
B |
$2.70 |
$12,325 |
D/D |
4,500 |
10,455 |
2.39 |
- |
|
Rudelius Robert James |
Director |
|
2011-11-01 |
4 |
B |
$2.70 |
$1,350 |
D/D |
500 |
5,955 |
2.31 |
- |
|
De Novo Management Ii, L.l.c. |
10% Owner |
|
2011-10-10 |
5 |
A |
$2.75 |
$15,001 |
I/I |
5,455 |
1,431,847 |
|
- |
|
Grooms Jamie Mark |
Director |
|
2011-10-10 |
4 |
A |
$2.75 |
$15,001 |
D/D |
5,455 |
218,534 |
|
- |
|
Rudelius Robert James |
Director |
|
2011-10-10 |
4 |
A |
$2.75 |
$15,001 |
D/D |
5,455 |
5,455 |
|
- |
|
Harper John Frederick |
Director |
|
2011-10-10 |
4 |
A |
$2.75 |
$15,001 |
D/D |
5,455 |
51,553 |
|
- |
|
Mandato Joseph M |
Director |
|
2011-10-10 |
4 |
A |
$2.75 |
$15,001 |
D/D |
5,455 |
5,455 |
|
- |
|
Gold Mark Stephen |
Director |
|
2011-10-10 |
4 |
A |
$2.75 |
$15,001 |
D/D |
5,455 |
5,455 |
|
- |
|
Gold Mark Stephen |
Director |
|
2011-09-30 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
125,523 |
|
- |
|
Gold Mark Stephen |
Director |
|
2011-09-30 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
107,690 |
|
- |
|
Harper John Frederick |
Director |
|
2011-09-30 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
86,557 |
|
- |
|
Harper John Frederick |
Director |
|
2011-09-30 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
55,416 |
|
- |
|
Zaderej Karen L. |
President and CEOOfficer |
|
2011-09-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
43,049 |
|
- |
|
Mandato Joseph M |
Director |
|
2011-09-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,426,392 |
|
- |
|
Engels John P |
Vice PresidentOfficer |
|
2011-09-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
90,698 |
|
- |
|
Gold Mark Stephen |
Director |
|
2011-09-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
376,226 |
|
- |
|
Harper John Frederick |
Director |
|
2011-09-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
46,098 |
|
- |
|
538 Records found
|
|
Page 21 of 22 |
|
|